Oral PCSK9 Inhibitor - Safety and Efficacy in Hypercholesterolemia with Dr. Ballantyne

FITsOnTheGO
FITsOnTheGO
7,078
0
Published 2023-03-07
Dr. Christie Ballantyne discusses his #LBCT - Efficacy and Safety of the Oral PCSK9 Inhibitor in the treatment of hypercholesterolemia with Dr. Ronstan Lobo
All Comments (3)
  • @cathycathy6295
    When will the oral Inhibitor be available and will side effects be as severe for some as the inj. form?
  • @cuongly6685
    Is it true that the PCSK9 inhibitors cause fatty liver? TIA.